Peroxidase activity of myoglobin is enhanced by chemical mutation of heme-propionates

Citation
T. Hayashi et al., Peroxidase activity of myoglobin is enhanced by chemical mutation of heme-propionates, J AM CHEM S, 121(34), 1999, pp. 7747-7750
Citations number
37
Categorie Soggetti
Chemistry & Analysis",Chemistry
Journal title
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
ISSN journal
00027863 → ACNP
Volume
121
Issue
34
Year of publication
1999
Pages
7747 - 7750
Database
ISI
SICI code
0002-7863(19990901)121:34<7747:PAOMIE>2.0.ZU;2-H
Abstract
Peroxidase activity of a myoglobin reconstituted with a chemically modified heme 1 is reported. The heme 1 bearing a total of eight carboxylates bound to the terminal of propionate side chains is incorporated into apomyoglobi n from horse heart to obtain a new reconstituted myoglobin, rMb(l), with a unique binding domain structure. The UV-vis, CD, and NMR spectra of rMb(l) are comparable with those of native myoglobin, nMb. The mixing of rMb(l) wi th hydrogen peroxide yields a peroxidase compound II-like species, rMb(l)-I I, since the spectrum of rMb(1)-II is identical with that observed for nMb. Stoichiometric oxidation of several small molecules by rMb(1)-II, demonstr ates the significant reactivity. (i) The oxidation of cationic substrate su ch as [Ru(NH3)(6)](2+) by rMb(1)-II is faster than that observed far oxofer ryl species of nMb, nMb-II. (ii) Anionic substrates such as ferrocyanide ar e unsuitable for the oxidation by rMb(1)-II. (iii) Oxidations of catechol, hydroquinone, and guaiacol are dramatically enhanced by rMb(l)-II(14-32- fo ld) compared to those observed for nMb-II. Thus, the chemical modification of heme-propionates can alter substrate specificity. Steady-state kinetic m easurements indicate that both the reactivity and substrate affinity toward guaiacol oxidation by rMb(1) are improved, so that the specificity, k(cat) /K-m, is 13-fold higher than that in nMb. This result strongly suggests tha t the artificially modified heme-propionates may increase the accessibility of neutral aromatic substrates to the heme active site. The present work d emonstrates that the chemical mutation of prosthetic group is a new strateg y to create proteins with engineered function.